NCCN Oncology Research Program (ORP)
NCCN Enzalutamide Research Grant Opportunity Submit by April 27, 2015
Study Proposal Submission-NCCN RMS
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP Investigator Steering Committee
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Insights: Analytics, Research & Consulting
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Research & Business Resources
The National Comprehensive Cancer Network® (NCCN®) has established the Affiliate Research Consortium (ARC) for affiliates of NCCN Member Institutions, giving community research sites access to cutting-edge research opportunities.
The ARC mission is to foster and promote innovative research to improve cancer outcomes for cancer patients by combining the diverse expertise of NCCN Member Institutions’ researchers and community partners. NCCN's Oncology Research Program (ORP) qualifies sites, offers research opportunities, and oversees all studies.
Approved NCCN Member Institution Affiliates:
- Virtua, which includes:
Hematology Oncology Associates of South Jersey, Mt. Holly, NJ
Comprehensive Cancer and Hematology Specialists, Voorhees, NJ
Principal Investigator: James Lee, MD
*Listing as of 12/11/2014
For additional information on the NCCN Affiliate Research Consortium, please contact the NCCN ORP at 215.690.0571 or ORP@nccn.org.